Correlates of stigma for patients with cancer: a systematic review and meta-analysis
Zehao Huang1, Ting Yu1, Siyu Wu2
1Nursing Department, Lingnan Branch of the Third Affiliated Hospital of Sun Yat-sen University, No. 2693 Kaichuang Street, Huangpu District, Guangzhou, China.
Objective:
The systematic review and meta-analysis was performed to summarize the available evidence and identify the correlates of cancer stigma.
Methods:
PubMed, EMBASE, Web of Science, the Cochrane Library, and PsycINFO were electronically searched to identify eligible studies about correlates of stigma for patients with cancer. Two reviewers independently screened the literature, extracted data, and assessed the risk of bias of included studies. A meta-analysis was performed using the statistical program R.
Results:
Thirty-one studies involving a total of 7114 patients were included in the systematic review and meta-analysis. The results of the meta-analysis showed that cancer stigma shared positive associations with male gender, symptoms, depression, anxiety, body image loss, self-blame, social constraint, intrusive thoughts, and ambivalence over emotional expression, and negative associations with income, NK cell subsets, QOL, self-esteem, self-efficacy, cancer screening attendance, doctor's empathy, and medical satisfaction. The results of the descriptive analysis indicated that cancer stigma was positively associated with self-perception of aging, anger, internal attributions, stressful life events, self-perceived burden, and sleep dysfunction, while negatively associated with patient-provider communication and sleep quality.
Conclusion:
Healthcare staff should pay attention to the identified correlates of cancer stigma. The results of our research can inform the design of interventions to reduce stigma and to improve clinical outcomes in people with cancer.
Related Concept Videos
Cancer Survival Analysis
Psychoneuroimmunology: Diabetes and Cancer
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
The Tumor Microenvironment
Cancer
Treatment Resistant Cancers

